LC-MS-MS to detect and identify four beta-agonists and quantify clenbuterol in liver†

Abstract

European legislation forbids the use of beta-agonists as growth-promoting substances in cattle raised for human consumption. However, the use of beta-agonists is allowed as a therapeutic treatment of tocolysis for female cattle during calving and of respiratory diseases and tocolysis for horses not raised for human consumption. A maximum residue limit (MRL) of 0.5 µg kg^–1 for clenbuterol in the liver of cattle and horses is proposed by law. Residues of beta-agonists in liver are identified with LC-MS-MS. Using ion trap technology, it was possible to identify each analyte without the need to resolve completely the chromatographic peaks. For each analyte, specific fragment ion spectra were obtained. The coeluting or incompletely resolved peaks were separated mass spectrometrically. For tulobuterol, bromobuterol and mabuterol, qualitative information was obtained. All beta-agonists could be detected up to a concentration of 0.1 µg kg^–1. For clenbuterol, a limited quantitative validation was performed. A working range was defined for which the method was applicable. Quantification was based on the integration of the response of the analytes in spiked blank liver samples. The mean recovery was 15%. The relative standard deviation (RSD) values at different concentrations were below the maximum allowed RSD. The limit of detection of clenbuterol was 0.11 µg kg^–1. The limit of quantification was 0.21 µg kg^–1. It was possible to quantify clenbuterol below one-half of the MRL. The advantage of this method is the ease of use of the mass spectrometric separation to qualify and quantify the presence of four beta-agonists in liver.

References

1. J. P. Hanrahan, Proceedings of the Seminar in the CEC Program of Coordination of Research in Animal Husbandry, Brussels, 19–20 May, Elsevier, London, 1987, p. 193.
2. A. R. Peters, Vet. Rec., 1989, 124, 417.
3. J. F. Martinez-Navarro, Lancet, 1990, 336, 1311.
4. C. Pulce, D. Lamaison, G. Keck, C. Bostvironnois, J. Nicolas and J. Descotes, Vet. Human Toxicol., 1991, 33, 480–481.
5. M. P. Montrade, B. Le Bizec, F. Manteau and F. Andre, Food Addit. Contam., 1995, 12, 625.
6. M. J. Sauer, R. J. H. Pickett and A. L. MacKenzie, Anal. Chim. Acta, 1993, 275, 195.
7. M. J. Sauer, R. J. H. Pickett, S. Limer and S. N. Dixon, J. Vet. Pharmacol. Ther., 1995, 18, 81.
8. H. H. D. Meyer, L. Rinke and I. Dursch, J. Chromatogr., 1991, 564, 551.
9. V. M. Moretti, C. Pieramati, F. Valfrè and O. Olivieri, Proc. Euroresidue III, 1996, pp. 499–503.
10. P. Gonzalez, C. A. Fente, C. Franco, B. Vazquez, E. Quinto and A. Cepada, J. Chromatogr., 1997, 693, 321.
11. H. Hooijerink, R. Schilt, E. O. van Bennekom and F. A. Huf, J. Chromatogr., 1994, 660, 303.
12. P. Batjoens, D. Courtheyn, H. F. De Brabander, J. Vercammen, K. De Wasch and M. Logghe, J. Chromatogr., 1996, 750, 133.
13. W. J. Blanchflower and D. G. Kennedy, Biomed. Environ. Mass Spectrom., 1989, 18, 935.
14. L. Debrauwer, G. Delous and G. Bories, Chromatographia, 1993, 36, 218.
15. D. Courtheyn, C. Desaever and R. Verhe, J. Chromatogr., 1991, 564, 537.
16. J. Cai and J. Henion, J. Chromatogr., 1997, 691, 357.
17. D. R. Doerge, S. Bajic Lowes and S. Lowes, Application Note 208, Fisons Instruments, Cheshire, UK, 1993.
18. W. Verwaal, M. Van Bavel, A. Boot, J. Bravenboer, F. de Goey, C. Maas and A. van der Putten, De Ware(n)-Chemicus, 1996, 26, 17.